284 related articles for article (PubMed ID: 37935403)
21. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
22. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
Goff ZD; Calkins H
Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
[TBL] [Abstract][Full Text] [Related]
23. Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
Gasperetti A; Carrick RT; Costa S; Compagnucci P; Bosman LP; Chivulescu M; Tichnell C; Murray B; Tandri H; Tadros R; Rivard L; van den Berg MP; Zeppenfeld K; Wilde AAM; Pompilio G; Carbucicchio C; Dello Russo A; Casella M; Svensson A; Brunckhorst CB; van Tintelen JP; Platonov PG; Haugaa KH; Duru F; Te Riele ASJM; Khairy P; Tondo C; Calkins H; James CA; Saguner AM; Cadrin-Tourigny J
Circulation; 2022 Nov; 146(19):1434-1443. PubMed ID: 36205131
[TBL] [Abstract][Full Text] [Related]
24. Predicting Sudden Cardiac Death in Genetic Heart Disease.
Cadrin-Tourigny J; Tadros R
Can J Cardiol; 2022 Apr; 38(4):479-490. PubMed ID: 35108574
[TBL] [Abstract][Full Text] [Related]
25. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
Bosman LP; Te Riele ASJM
Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
[TBL] [Abstract][Full Text] [Related]
26. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
27. Arrhythmogenic Right Ventricular Cardiomyopathy.
Krahn AD; Wilde AAM; Calkins H; La Gerche A; Cadrin-Tourigny J; Roberts JD; Han HC
JACC Clin Electrophysiol; 2022 Apr; 8(4):533-553. PubMed ID: 35450611
[TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
[TBL] [Abstract][Full Text] [Related]
29. Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH; Platonov PG; Svensson A; Jensen HK; Rootwelt-Norberg C; Dahlberg P; Madsen T; Frederiksen TC; Heliö T; Haugaa KH; Bundgaard H; Svendsen JH
Europace; 2022 Feb; 24(2):306-312. PubMed ID: 34279601
[TBL] [Abstract][Full Text] [Related]
30. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries.
Haugaa KH; Bundgaard H; Edvardsen T; Eschen O; Gilljam T; Hansen J; Jensen HK; Platonov PG; Svensson A; Svendsen JH
Scand Cardiovasc J; 2015; 49(6):299-307. PubMed ID: 26395672
[TBL] [Abstract][Full Text] [Related]
31. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
[TBL] [Abstract][Full Text] [Related]
32. Management of arrhythmogenic right ventricular cardiomyopathy.
Al-Aidarous S; Protonotarios A; Elliott PM; Lambiase PD
Heart; 2024 Jan; 110(3):156-162. PubMed ID: 37433658
[TBL] [Abstract][Full Text] [Related]
33. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
34. Management of arrhythmogenic right ventricular cardiomyopathy.
Silvano M; Mastella G; Zorzi A; Migliore F; Pilichou K; Bauce B; Rigato I; Perazzolo Marra M; Iliceto S; Thiene G; Basso C; Corrado D
Minerva Med; 2016 Aug; 107(4):194-216. PubMed ID: 27186923
[TBL] [Abstract][Full Text] [Related]
35. Arrhythmogenic Cardiomyopathy.
Corrado D; Basso C; Judge DP
Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification in arrhythmogenic right ventricular cardiomyopathy.
Silvano M; Corrado D; Köbe J; Mönnig G; Basso C; Thiene G; Eckardt L
Herzschrittmacherther Elektrophysiol; 2013 Dec; 24(4):202-8. PubMed ID: 24113835
[TBL] [Abstract][Full Text] [Related]
37. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
[TBL] [Abstract][Full Text] [Related]
38. Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy.
Trancuccio A; Kukavica D; Sugamiele A; Mazzanti A; Priori SG
Card Electrophysiol Clin; 2023 Sep; 15(3):349-365. PubMed ID: 37558305
[TBL] [Abstract][Full Text] [Related]
39. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
[TBL] [Abstract][Full Text] [Related]
40. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
